Tag: AbD Serotec

Monoclonal antibodies target Herceptin

LATEST addition to the range of anti-idiotypic antibodies from AbD Serotec are used to target Herceptin (Trastuzumab), an anti-cancer drug. The six new antibodies are useful for monitoring patient serum for Herceptin levels, and have potential applications in preclinical research.…